Dbv Technologies SA (NASDAQ:DBVT)
| 1.87 Delayed Data As of May 26 |  +0.03 / +1.63%Today’s Change | 1.08 Today|||52-Week Range 3.43 | +22.22% Year-to-Date |
Latest DBVT News | Press Releases
No recent news for Dbv Technologies SA.
Today’s Trading
| Previous close | 1.84 |
| Today’s open | 1.86 |
| Day’s range | 1.84 - 1.87 |
| Volume | 1,264 |
| Average volume (3 months) | 79,843 |
| Market cap | $368.4M |
Data as of 3:57pm ET, 05/26/2023
Growth & Valuation
| Earnings growth (last year) | +30.14% |
| Earnings growth (this year) | +38.90% |
| Earnings growth (next 5 years) | +17.50% |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.90 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TIHETaihe Group Inc | 0.00 | 0.00% |
| AMEUFAnteris Technologies... | +0.23 | +1.48% |
| AMRNAmarin Corporation P... | 0.00 | 0.00% |
| --Oxford Biomedica PLC | 0.00 | 0.00% |
Data as of 05/29/2023
Financials
| Next reporting date | July 31, 2023 |
| EPS forecast (this quarter) | -$0.21 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$96.3M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Montrouge, Ile-de-france |
Forecasts
